Stay updated with breaking news from Celularity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celularity Inc. (NASDAQ:CELU – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,390,000 shares, an increase of 10.8% from the May 15th total of 3,060,000 shares. Currently, 4.0% of the company’s shares are sold short. Based on […]
Celularity Inc. (NASDAQ:CELU – Get Rating) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,390,000 shares, an increase of 10.8% from the May 15th total of 3,060,000 shares. Based on an average trading volume of 463,700 shares, the days-to-cover ratio is currently […]
Data published online in the journal Cytotherapy demonstrate that CRISPR-mediated tissue factor gene knockout in allogeneic stromal cells leads to significantly lower tissue factor expression,... | June 1, 2023
Builds on Celularity's December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and clinical and investigational stage cellular therapeutic programsMarks
Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and clinical and investigational...